Downloading...
Download

Bagger

BANKERA - BNK ready for a huge leg up 155%Seems like Banera BNK has been in a consolidation phase for a period of time, Looking @ Etherscan the top 100 holders hold approx 40%+- With a number of these buying in the past 3-6 months Initial target is a HUGE 155% growth, it appears an descending triangle pattern is due to complete. Then retracement back to a what appears to be a soft support/resistance line. Provided this holds a further 290% (from current level) is achievable re-testing the 2nd resistance level. Huge potential here! Full diclosure, I have purchased and now hold a parcel All information is for educational purposes for testing charting patters and fundaments, always looking for feedback, and not intended as investment advice or guidance
BLong
by Mickydublya
FCEL pt4First the factors against us -Weak price strength based on 9 day SMA -WEAK price direction based on 180 day SMA -DOWNward tend line So other than another shaky day in the overall market I think FCEL is consolidating to fill an old gap between 6.15 and 5.80. The lowest we've seen in the today (8/16/21) @ 5.94 then regaining some strength and holding support at 6.08. in all consider if the ads are in you favor before jumping in even though up side is massive how long are you willing to hold... Best
NASDAQ:FCELLong
by CosmicLoFy
1
Clinuvel (CUV) set up for the next 200-350% run-up!Chart pattern: Since 2014 a regular chart-pattern can be observed in the Clinuvel ( CUV ) chart. After one year of a strong run-up (mostly starting in late February), the stock reaches a local peak (around Sept-Nov) and starts a correction (around -35% to -50%), followed by a longer sideways consolidation. Then the year after late Feb the next run-up starts. After the FDA approval in October 2019 the stock peaked, followed again by a strong and long correction and consolidation. Currently, a new upmove started end of February 2021, bringing the stock from its recent correction low already up by 40% (20 AUD to 28 AUD). Assuming the regluar pattern repeats, the new upmove has already started end of February and should bring the stock up to 60-86 AUD (200-330%) by autumn 2021. Fundamental support of the coming run-up Clinuvel is an innovative Biotech-Company, based in Melbourne Australia (ASX listed) and the world leader in Melanocortin-Hormones. Clinuvel offers the product "Scenesse" (Afamelanotide), which is approved in Europe since 2014, in USA since 2019 and in Australia and Israel since 2020. The company has no debts and is highly profitable. There are several fundamental accelerators and good news to support a coming up-move: - Continues expansion of the product in Europe (more and more countries are approved and reimbursed) - Massive revenue growth expected in the USA, as the infrastructur for the distribution of Scenesse has been established now - New Marketing and brand building initiatives - New studies in place for label extension of the product -> Vitiligo Phase 3 program to be started soon (Clinuvel is in final alignment with the FDA) (billon dollar market) -> Ischemic stroke program: First study to be started shortly (billion dollar market) -> XP study to proof DNA repair capabilities of Scenesse -> Launch of OTC cosmetic products for mass market, with active ingredients for skin tanning (billion dollar market) Overall, the management of the company is highly bullish to reach the set goals.
ASX:CUVLong
by TBech
2
NVX Bulls Hunting +100%Novonix Limited (ASX: NVX) is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry with operations in the USA and Canada and sales in more than 14 countries. Bulls Hunting +100% Huge Fractal Bullish Pennant + Targets 1.925 & 2.800 From point of break Fib Extension Targets - (-0.272 & -0.618) looking achievable and lining up to Fractal Target Regions Market Structure forming within Pennant - Higher Low and Lower High indicating squeeze Fib Retracement - Huge bounce off the .5 Golden Pocket Level MACD - Indecisive oscillation indicating squeeze CCI - Still trending up and no signs of Divergence on the Daily Bollinger Band - We have been riding the 20 MA since April 24th Daily Resistance - 3 Touches on Daily Resistance, "4th Touch" incoming? Depending on your "Risk Management" & "Entry/Exit Strat" there are 2 entries. Point of Break/ Bottom trend of the Pennant. These Ideas are NOT 'Financial Advice'!. Scenarios are based off a mixture of TA and Fundamentals current at the time. All IMO GLTAH. Happy Hunting!!!
ASX:NVXLong
by Trader_Johnni
3